Treatment of high-burden hepatocellular carcinoma: an oncologist perspective
نویسندگان
چکیده
منابع مشابه
Treatment of high-burden hepatocellular carcinoma: an oncologist perspective
Hepatocellular carcinoma (HCC) is recognized as a major global healthcare burden. Although there have been tremendous improvements in cancer screening and treatment, HCC mortality rate remains high. Many patients with HCC present late to medical attention and thus are not candidates for curative treatment. They typically have high tumor burden at presentation showing heterogeneity in anatomical...
متن کاملPreclinical studies of 166Ho-chitosan for treatment of hepatocellular carcinoma
Introduction: Recently, due to the special characteristics of 166Ho and chitosan, 166Ho-chitosan complex was developed for treatment of tumors such as hepatocellular carcinoma. This complex has been lately prepared with high radiochemical purity in our lab. The preclinical studies of the complex however should be performed to evaluate the tracer concentration in target and...
متن کاملHepatocellular carcinoma from an immunologic perspective.
Hepatocellular carcinoma is the third most common cancer worldwide. It is an inflammation-associated cancer. Multiple investigators have demonstrated that analysis of the tumor microenvironment may be used to predict patient outcome, indicating the importance of local immune responses in this disease. In contrast with other types of cancer, in which surgery, radiation, and systemic cytotoxic ch...
متن کاملHepatocellular carcinoma from an immunological perspective
Word count (excluding references): 3146 Total number of figures and tables: 3 figures and 2 tables Research. Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract Hepatocellular carcinoma is the 3 rd most common cancer worldwide. It is an inflammation-associated cancer. Multiple investigators have demonstrated that analysis of the tumor m...
متن کاملHigh immunosuppressive burden in advanced hepatocellular carcinoma patients
The accumulation of immunosuppressive cells and exhausted effector T cells highlight an important immune dysfunction in advanced stage hepatocellular carcinoma (HCC) patients. These cells significantly hamper the efficacy immunotherapies and facilitate HCC progression. We have recently demonstrated that the multipronged depletion of immunosuppressive cells potentially restores effector T-cell f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Hepatoma Research
سال: 2018
ISSN: 2454-2520,2394-5079
DOI: 10.20517/2394-5079.2017.49